Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Status: Enrolling
Updated:  10/10/2017
UPMC Susquehanna
mi
from
Williamsport, PA
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Status: Enrolling
Updated: 10/10/2017
UPMC Susquehanna
mi
from
Williamsport, PA
Click here to add this to my saved trials
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Status: Enrolling
Updated:  10/10/2017
Marshfield Medical Center
mi
from
Marshfield, WI
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
A Double-Blind Phase III Trial of Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab or Placebo in Patients With Lymph Node Positive and High Risk Lymph Node Negative Breast Cancer
Status: Enrolling
Updated: 10/10/2017
Marshfield Medical Center
mi
from
Marshfield, WI
Click here to add this to my saved trials
Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
Clinical Implementation and Evaluation of MR Spectroscopy for Breast Cancer Detection
Status: Enrolling
Updated:  10/10/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
Evaluate the Use of the Magnetic Resonance Spectroscopy in Determining if the Breast Tumor is Benign or Malignant
Clinical Implementation and Evaluation of MR Spectroscopy for Breast Cancer Detection
Status: Enrolling
Updated: 10/10/2017
SUNY Upstate Medical University
mi
from
Syracuse, NY
Click here to add this to my saved trials
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Optical Biosensor for the Early Detection of Breast Cancer
Status: Enrolling
Updated:  10/11/2017
City of Hope Medical Center
mi
from
Duarte, CA
Nipple Secretion Samples in Detecting Breast Cancer in Patients and Healthy Participants Undergoing Breast Cancer Screening, Breast Diagnostic Studies, or Treatment for Benign Breast Disease
Optical Biosensor for the Early Detection of Breast Cancer
Status: Enrolling
Updated: 10/11/2017
City of Hope Medical Center
mi
from
Duarte, CA
Click here to add this to my saved trials
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated:  10/11/2017
Florida Cancer Center
mi
from
Fort Myers, FL
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated: 10/11/2017
Florida Cancer Center
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated:  10/11/2017
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated: 10/11/2017
Center for Cancer & Blood Disorders
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated:  10/11/2017
North Shore Hematology Oncology Assoaciates
mi
from
East Setauket, NY
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated: 10/11/2017
North Shore Hematology Oncology Assoaciates
mi
from
East Setauket, NY
Click here to add this to my saved trials
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated:  10/11/2017
New England Cancer Specialists
mi
from
Scarborough, ME
Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients
A Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients Who Are Candidates for Genomic Testing
Status: Enrolling
Updated: 10/11/2017
New England Cancer Specialists
mi
from
Scarborough, ME
Click here to add this to my saved trials
Breast Cancer Surveillance Consortium
Breast Cancer Surveillance Consortium Data Resource
Status: Enrolling
Updated:  10/11/2017
Group Health Cooperative
mi
from
Seattle, WA
Breast Cancer Surveillance Consortium
Breast Cancer Surveillance Consortium Data Resource
Status: Enrolling
Updated: 10/11/2017
Group Health Cooperative
mi
from
Seattle, WA
Click here to add this to my saved trials
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Status: Enrolling
Updated:  10/12/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12
Status: Enrolling
Updated: 10/12/2017
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
Status: Enrolling
Updated:  10/13/2017
Yale University
mi
from
New Haven, CT
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
A Pilot/Phase II Study of Gamma Knife Radiosurgery for Brain Metastases Using 3Tesla MRI and Rational Dose Selection
Status: Enrolling
Updated: 10/13/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Exemestane and Cyclophosphamide for Metastatic Breast Cancer
Phase II Trial of Exemestane With Immunomodulatory Cyclophosphamide in ER and/or PR-positive and HER2/Neu Negative Metastatic Breast Cancer
Status: Enrolling
Updated:  10/16/2017
NYU Cancer Center
mi
from
New York, NY
Exemestane and Cyclophosphamide for Metastatic Breast Cancer
Phase II Trial of Exemestane With Immunomodulatory Cyclophosphamide in ER and/or PR-positive and HER2/Neu Negative Metastatic Breast Cancer
Status: Enrolling
Updated: 10/16/2017
NYU Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts
Characterization of Breast Masses Using a New Method of Ultrasound Contrast Agent Imaging in 3D Mapping of Vascular Anomalies
Status: Enrolling
Updated:  10/16/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Evaluate Breast Masses Using a New Method of Ultrasound Contrast to Detect Abnormal Blood Flow in Breasts
Characterization of Breast Masses Using a New Method of Ultrasound Contrast Agent Imaging in 3D Mapping of Vascular Anomalies
Status: Enrolling
Updated: 10/16/2017
University of Michigan Health System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
Botulinum Toxin A in Tissue Expander Breast Reconstruction: A Double-Blinded Randomized Controlled Trial
Status: Enrolling
Updated:  10/17/2017
The Mayo Clinic
mi
from
Rochester, MN
Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction
Botulinum Toxin A in Tissue Expander Breast Reconstruction: A Double-Blinded Randomized Controlled Trial
Status: Enrolling
Updated: 10/17/2017
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
University of Kansas Cancer Center, 4350 Shawnee Mission Pkwy, Suite 1500, Mailstop 6004
mi
from
Fairway, KA
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
University of Kansas Cancer Center, 4350 Shawnee Mission Pkwy, Suite 1500, Mailstop 6004
mi
from
Fairway, KA
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
Magee-Womens Hospital
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
Sara Cannon Research Institute
mi
from
Nashville, TN
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
Sara Cannon Research Institute
mi
from
Nashville, TN
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
The Methodist Hospital Research Institute
mi
from
Houston, TX
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
The Methodist Hospital Research Institute
mi
from
Houston, TX
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
Indiana University Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
The Cancer Institute of New Jersey
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
Weill-Cornell Medical College
mi
from
New York, NY
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
Weill-Cornell Medical College
mi
from
New York, NY
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
Fox Chase Cancer Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated:  10/17/2017
Montefiore Medical Center, MMC Medical Park at Eastchester
mi
from
The Bronx, NY
Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients
A Single Arm, Preoperative, Pilot Study to Evaluate the Safety and Biological Effects of Orally Administered Reparixin in Early Breast Cancer Patients Who Are Candidates for Surgery
Status: Enrolling
Updated: 10/17/2017
Montefiore Medical Center, MMC Medical Park at Eastchester
mi
from
The Bronx, NY
Click here to add this to my saved trials
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
Status: Enrolling
Updated:  10/17/2017
UT Southwestern Medical Center - Advanced Imaging Research Center
mi
from
Dallas, TX
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
Investigation of Diagnostic Improvement Gained Through Optimization of MR Methods for Breast Cancer Detection
Status: Enrolling
Updated: 10/17/2017
UT Southwestern Medical Center - Advanced Imaging Research Center
mi
from
Dallas, TX
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Kaiser Permanente-San Diego Zion
mi
from
San Diego, CA
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Kaiser Permanente-San Diego Zion
mi
from
San Diego, CA
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Kaiser Permanente-San Marcos
mi
from
San Marcos, CA
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Kaiser Permanente-San Marcos
mi
from
San Marcos, CA
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Greenwich Hospital
mi
from
Greenwich, CT
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Greenwich Hospital
mi
from
Greenwich, CT
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
The Hartford Hospital
mi
from
Hartford, CT
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
The Hartford Hospital
mi
from
Hartford, CT
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Midstate Medical Center
mi
from
Meriden, CT
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Midstate Medical Center
mi
from
Meriden, CT
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
The Hospital of Central Connecticut
mi
from
New Britain, CT
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
The Hospital of Central Connecticut
mi
from
New Britain, CT
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Helen F. Graham Cancer Center
mi
from
Newark, DE
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Helen F. Graham Cancer Center
mi
from
Newark, DE
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Medical Oncology Hematology Consultants
mi
from
Newark, DE
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Medical Oncology Hematology Consultants
mi
from
Newark, DE
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Regional Hematology and Oncology PA
mi
from
Newark, DE
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Regional Hematology and Oncology PA
mi
from
Newark, DE
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Christiana Care Health System - Christiana Hospital
mi
from
Newark, DE
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
John Fitzgerald Kennedy Medical Center
mi
from
Atlantis, FL
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
John Fitzgerald Kennedy Medical Center
mi
from
Atlantis, FL
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Northwestern University
mi
from
Chicago, IL
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Ingalls Memorial Hospital
mi
from
Harvey, IL
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Ingalls Memorial Hospital
mi
from
Harvey, IL
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Edward Hospital Cancer Center
mi
from
Naperville, IL
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Edward Hospital Cancer Center
mi
from
Naperville, IL
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Edward Hospital/Cancer Center?Plainfield
mi
from
Plainfield, IL
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Edward Hospital/Cancer Center?Plainfield
mi
from
Plainfield, IL
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Springfield Clinic
mi
from
Springfield, IL
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Springfield Clinic
mi
from
Springfield, IL
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Memorial Medical Center
mi
from
Springfield, IL
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Memorial Medical Center
mi
from
Springfield, IL
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
IU Health West Hospital
mi
from
Avon, IN
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
IU Health West Hospital
mi
from
Avon, IN
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Indiana University Melvin and Bren Simon Cancer Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Memorial Regional Cancer Center Day Road
mi
from
Mishawaka, IN
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Memorial Regional Cancer Center Day Road
mi
from
Mishawaka, IN
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Memorial Hospital of South Bend
mi
from
South Bend, IN
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Memorial Hospital of South Bend
mi
from
South Bend, IN
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Cancer Center of Kansas, PA - Dodge City
mi
from
Dodge City, KA
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Cancer Center of Kansas, PA - El Dorado
mi
from
El Dorado, KA
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Lawrence Memorial Hospital
mi
from
Lawrence, KA
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Lawrence Memorial Hospital
mi
from
Lawrence, KA
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Cancer Center of Kansas, PA - Salina
mi
from
Salina, KA
Click here to add this to my saved trials
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated:  10/19/2017
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Prospective Study of Magnetic Resonance Imaging (MRI) and Multiparameter Gene Expression Assay in Ductal Carcinoma In Situ (DCIS)
Status: Enrolling
Updated: 10/19/2017
Cancer Center of Kansas, PA - Wellington
mi
from
Wellington, KA
Click here to add this to my saved trials